Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

The expression of RANKL and OPG in the various grades of osteoarthritic cartilage.

Upton AR, Holding CA, Dharmapatni AA, Haynes DR.

Rheumatol Int. 2012 Feb;32(2):535-40. doi: 10.1007/s00296-010-1733-6. Epub 2011 Jan 23.

PMID:
21259010
[PubMed - indexed for MEDLINE]
2.

The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304.

PMID:
18565252
[PubMed - indexed for MEDLINE]
3.

The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.

Komuro H, Olee T, Kühn K, Quach J, Brinson DC, Shikhman A, Valbracht J, Creighton-Achermann L, Lotz M.

Arthritis Rheum. 2001 Dec;44(12):2768-76.

PMID:
11762937
[PubMed - indexed for MEDLINE]
4.

Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.

Moreno-Rubio J, Herrero-Beaumont G, Tardio L, Alvarez-Soria MA, Largo R.

Arthritis Rheum. 2010 Feb;62(2):478-88. doi: 10.1002/art.27204.

PMID:
20112374
[PubMed - indexed for MEDLINE]
Free Article
5.

The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.

Zupan J, Komadina R, Marc J.

J Biomed Sci. 2012 Mar 1;19:28. doi: 10.1186/1423-0127-19-28.

PMID:
22380539
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Enhanced expression of interleukin-6, matrix metalloproteinase-13, and receptor activator of NF-kappaB ligand in cells derived from osteoarthritic subchondral bone.

Sakao K, Takahashi KA, Mazda O, Arai Y, Tonomura H, Inoue A, Saito M, Fujioka M, Takamiya H, Imanishi J, Kubo T.

J Orthop Sci. 2008 May;13(3):202-10. doi: 10.1007/s00776-008-1227-5. Epub 2008 Jun 6.

PMID:
18528653
[PubMed - indexed for MEDLINE]
7.

Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.

Marzaioli V, McMorrow JP, Angerer H, Gilmore A, Crean D, Zocco D, Rooney P, Veale D, Fearon U, Gogarty M, McEvoy AN, Stradner MH, Murphy EP.

Arthritis Rheum. 2012 Oct;64(10):3290-301. doi: 10.1002/art.34554.

PMID:
22674155
[PubMed - indexed for MEDLINE]
Free Article
8.

Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.

Tat SK, Pelletier JP, Vergés J, Lajeunesse D, Montell E, Fahmi H, Lavigne M, Martel-Pelletier J.

Arthritis Res Ther. 2007;9(6):R117.

PMID:
17996099
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.

Tat SK, Pelletier JP, Mineau F, Caron J, Martel-Pelletier J.

Bone. 2011 Sep;49(3):559-67. doi: 10.1016/j.bone.2011.06.005. Epub 2011 Jun 12.

PMID:
21700005
[PubMed - indexed for MEDLINE]
10.

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males.

Findlay D, Chehade M, Tsangari H, Neale S, Hay S, Hopwood B, Pannach S, O'Loughlin P, Fazzalari N.

Arthritis Res Ther. 2008;10(1):R2. doi: 10.1186/ar2348. Epub 2008 Jan 8.

PMID:
18182105
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.

Giner M, Rios MA, Montoya MA, Vázquez MA, Naji L, Pérez-Cano R.

J Steroid Biochem Mol Biol. 2009 Jan;113(1-2):46-51. doi: 10.1016/j.jsbmb.2008.11.005. Epub 2008 Nov 27.

PMID:
19073256
[PubMed - indexed for MEDLINE]
12.

Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis.

Kwan Tat S, Amiable N, Pelletier JP, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J.

Rheumatology (Oxford). 2009 Dec;48(12):1482-90. doi: 10.1093/rheumatology/kep300. Epub 2009 Sep 17.

PMID:
19762475
[PubMed - indexed for MEDLINE]
Free Article
13.

Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.

Ainola M, Mandelin J, Liljeström M, Konttinen YT, Salo J.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):240-6.

PMID:
18565244
[PubMed - indexed for MEDLINE]
14.

The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.

Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM.

J Bone Miner Res. 2001 Jun;16(6):1015-27.

PMID:
11393778
[PubMed - indexed for MEDLINE]
15.

[Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients].

Wang J, Gao H, Wang K, Li W, Shi Z, Zhang M.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Jul;23(7):777-80. Chinese.

PMID:
19662974
[PubMed - indexed for MEDLINE]
16.

RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.

Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G.

Arthritis Res Ther. 2012 Jun 18;14(3):R149. doi: 10.1186/ar3884.

PMID:
22709525
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].

Wang J, Wang K, Shi Z, Zhang M.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Oct;22(10):1161-4. Chinese.

PMID:
18979868
[PubMed - indexed for MEDLINE]
18.

Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.

Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.

Bone. 2004 Jul;35(1):256-65.

PMID:
15207766
[PubMed - indexed for MEDLINE]
19.

Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins.

Silvestrini G, Ballanti P, Leopizzi M, Gualtieri N, Sardella D, Monnazzi P, Simeoni S, Sebastiani M, Bonucci E, Patacchioli FR.

J Mol Histol. 2007 Jun;38(3):215-26. Epub 2007 May 3.

PMID:
17476578
[PubMed - indexed for MEDLINE]
20.

Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.

Schubert A, Schulz H, Emons G, Gründker C.

Gynecol Endocrinol. 2008 Jun;24(6):331-8. doi: 10.1080/09513590802095845.

PMID:
18584413
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk